Hala O. Eltwisy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hala O. Eltwisy has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Howida Omar Twisy
Lecturer of Dermatology, Venereology and Andrology Department, Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt
1 shared publication - Ibrahim Mohamoud Sayed
Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell, Lowell, MA, United States
1 shared publication - Mahmoud Hr Hafez
International Scholar, African Leadership Academy, 1050 Printech Road, Laser Park, Honeydew, Johannesburg 2040, South Africa
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 31 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1130
Clinical Infections, Antibiotic Resistance, and Pathogenesis of Staphylococcus haemolyticus
Staphylococcus haemolyticus (S. haemolyticus) constitutes the main part of the human skin microbiota. It is widespread in hospitals and among medical staff, resulting in being an emerging microbe causing nosocomial infections. S. haemolyticus, especially strains that cause nosocomial infections, are more resistant to antibiotics than other coagulase-negative Staphylococci. There is clear evidence that the resistance genes can be acquired by other Staphylococcus species through S. haemolyticus. Severe infections are recorded with S. haemolyticus such as meningitis, endocarditis, prosthetic joint infections, bacteremia, septicemia, peritonitis, and otitis, especially in immunocompromised patients. In addition, S. haemolyticus species were detected in dogs, breed kennels, and food animals. The main feature of pathogenic S. haemolyticus isolates is the formation of a biofilm which is involved in catheter-associated infections and other nosocomial infections. Besides the biofilm formation, S. haemolyticus secretes other factors for bacterial adherence and invasion such as enterotoxins, hemolysins, and fibronectin-binding proteins. In this review, we give updates on the clinical infections associated with S. haemolyticus, highlighting the antibiotic resistance patterns of these isolates, and the virulence factors associated with the disease development.
- 31 May 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1130
Top Cited PapersOpen AccessClinical Infections, Antibiotic Resistance, and Pathogenesis of Staphylococcus haemolyticus
Staphylococcus haemolyticus (S. haemolyticus) constitutes the main part of the human skin microbiota. It is widespread in hospitals and among medical staff, resulting in being an emerging microbe causing nosocomial infections. S. haemolyticus, especially strains that cause nosocomial infections, are more resistant to antibiotics than other coagulase-negative Staphylococci. There is clear evidence that the resistance genes can be acquired by other Staphylococcus species through S. haemolyticus. Severe infections are recorded with S. haemolyticus such as meningitis, endocarditis, prosthetic joint infections, bacteremia, septicemia, peritonitis, and otitis, especially in immunocompromised patients. In addition, S. haemolyticus species were detected in dogs, breed kennels, and food animals. The main feature of pathogenic S. haemolyticus isolates is the formation of a biofilm which is involved in catheter-associated infections and other nosocomial infections. Besides the biofilm formation, S. haemolyticus secretes other factors for bacterial adherence and invasion such as enterotoxins, hemolysins, and fibronectin-binding proteins. In this review, we give updates on the clinical infections associated with S. haemolyticus, highlighting the antibiotic resistance patterns of these isolates, and the virulence factors associated with the disease development.